ST Pharm Co.Ltd (237690) — Cash Flow-to-Debt Ratio
ST Pharm Co.Ltd (237690) has a Cash Flow-to-Debt Ratio of -0.11x as of December 2025, meaning its operating cash flow of ₩-21.16 Billion could theoretically repay 0% of its total liabilities (₩189.56 Billion) in one year. See free cash flow generation of ST Pharm Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ST Pharm Co.Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for ST Pharm Co.Ltd across 11 annual periods. Also explore ST Pharm Co.Ltd (237690) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ST Pharm Co.Ltd (2015–2025)
Year-by-year debt coverage analysis for ST Pharm Co.Ltd. For market capitalisation and broader financial context, see market value of ST Pharm Co.Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩13.99 Billion | ₩189.56 Billion | ▼ -85.2% |
| 2024 | 0.50x | ₩109.45 Billion | ₩218.88 Billion | ▲ +11012.0% |
| 2023 | 0.00x | ₩1.30 Billion | ₩288.53 Billion | ▼ -85.1% |
| 2022 | 0.03x | ₩7.03 Billion | ₩233.02 Billion | ▼ -27.1% |
| 2021 | 0.04x | ₩7.27 Billion | ₩175.59 Billion | ▲ +129.7% |
| 2020 | -0.14x | ₩-20.93 Billion | ₩150.24 Billion | ▲ +81.7% |
| 2019 | -0.76x | ₩-30.52 Billion | ₩40.12 Billion | ▼ -198.4% |
| 2018 | 0.77x | ₩10.77 Billion | ₩13.94 Billion | ▼ -56.8% |
| 2017 | 1.79x | ₩54.44 Billion | ₩30.42 Billion | ▲ +92.2% |
| 2016 | 0.93x | ₩50.78 Billion | ₩54.53 Billion | ▲ +173.0% |
| 2015 | 0.34x | ₩35.82 Billion | ₩105.04 Billion | — |